Evgen Pharma plcPatent and Know-How License Agreement • August 2nd, 2023
Contract Type FiledAugust 2nd, 2023company developing sulforaphane-based medicines, and partner JuvLife Ltd, a division of Juvenescence Ltd, have agreed to terminate the Patent and Know-how License Agreement for Evgen's Sulforadex® sulforaphane stabilisation technology.